StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

Benitec Biopharma operating margin

Operating margin is operating income as a percentage of revenue.

Benitec Biopharma's operating margin for the twelve months ending Mar 31, 2024 was -307028.6%. For fiscal 2023 it was -25441.3%, against -24457.5% the year before. The highest annual figure on record is 21.2% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Jun 30, 2023-25441.3%−983.8
FY2022Jun 30, 2022-24457.5%−1413.5
FY2021Jun 30, 2021-23044.1%−14925.4
FY2020Jun 30, 2020-8118.6%−8139.8
FY2019Jun 30, 201921.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2023CQ2 2023Jun 30, 2023-65000.0%−45660.0
Q3 FY2023CQ1 2023Mar 31, 2023-8038.9%+184711.1
Q2 FY2023CQ4 2022Dec 31, 2022-40071.4%+339228.6
Q3 FY2022CQ1 2022Mar 31, 2022-7208.3%+318691.7
Q2 FY2022CQ4 2021Dec 31, 2021-19340.0%−14449.1
Q4 FY2021CQ2 2021Jun 30, 2021-192750.0%−185210.7
Q3 FY2021CQ1 2021Mar 31, 2021-379300.0%−376558.4
Q2 FY2021CQ4 2020Dec 31, 2020-325900.0%−322366.7
Q1 FY2021CQ3 2020Sep 30, 2020-4890.9%–
Q3 FY2020CQ1 2020Mar 31, 2020-7539.3%–
Q2 FY2020CQ4 2019Dec 31, 2019-2741.6%–
Q1 FY2020CQ3 2019Sep 30, 2019-3533.3%–

More Benitec Biopharma figures

See a number that looks wrong?